论文部分内容阅读
甲状腺功能亢进症(以下简称“甲亢”)是内分泌系统一种常见的疾病,病因仍未完全阐明。目前认为与免疫监护缺陷有关。在病因性治疗措施问世之前,甲亢的治疗仍须依赖传统的减少甲状腺激素分泌量的方法,包括抗甲状腺药物、甲状腺次全切除术和放射性碘治疗。抗甲状腺药物的应用始于四十年代初期,至今仍是治疗甲亢的主要手段,如何合理用药是临床医生经常遇到的课题。为了提高甲亢治疗的水平,现将抗甲状腺药物合理应用的有关问题介绍如下。
Hyperthyroidism (hereinafter referred to as “hyperthyroidism”) is a common disease of the endocrine system, the cause has not been fully elucidated. Currently considered to be related to immunological guardianship defects. Prior to the advent of pathogenic treatment, the treatment of hyperthyroidism still had to rely on traditional methods of reducing thyroid hormone secretion, including antithyroid drugs, subtotal thyroidectomy and radioactive iodine therapy. The application of antithyroid drugs began in the early 1940s and is still the main method of treating hyperthyroidism. How to treat it properly is a common issue for clinicians. In order to improve the level of treatment of hyperthyroidism, antithyroid drugs are now the appropriate application of the issues described below.